SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9776187
Source:
http://linkedlifedata.com/resource/pubmed/id/9776187
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002131
,
umls-concept:C0007137
,
umls-concept:C0008976
,
umls-concept:C0017296
,
umls-concept:C0460004
,
umls-concept:C1274040
pubmed:issue
10
pubmed:dateCreated
1998-10-28
pubmed:abstractText
To determine the safety and efficacy of an immunogenic gene therapy using a drug designed to produce expression of a foreign class I major histocompatibility complex protein in patients with head and neck cancer.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA65769
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8603209
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Allovectin-7
,
http://linkedlifedata.com/resource/pubmed/chemical/DNA
,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Recombinant
,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B7 Antigen
,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0886-4470
pubmed:author
pubmed-author:ArmstrongSS
,
pubmed-author:BalakrishnanKK
,
pubmed-author:BiddingerP WPW
,
pubmed-author:GleichL LLL
,
pubmed-author:GluckmanJ LJL
,
pubmed-author:MillerM AMA
,
pubmed-author:SaavedraH IHI
,
pubmed-author:StambrookP JPJ
,
pubmed-author:WilsonK MKM
pubmed:issnType
Print
pubmed:volume
124
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1097-104
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9776187-Adult
,
pubmed-meshheading:9776187-Aged
,
pubmed-meshheading:9776187-Carcinoma, Squamous Cell
,
pubmed-meshheading:9776187-Combined Modality Therapy
,
pubmed-meshheading:9776187-DNA
,
pubmed-meshheading:9776187-DNA, Recombinant
,
pubmed-meshheading:9776187-Female
,
pubmed-meshheading:9776187-Gene Therapy
,
pubmed-meshheading:9776187-HLA-B7 Antigen
,
pubmed-meshheading:9776187-Head and Neck Neoplasms
,
pubmed-meshheading:9776187-Histocompatibility Testing
,
pubmed-meshheading:9776187-Humans
,
pubmed-meshheading:9776187-Immunohistochemistry
,
pubmed-meshheading:9776187-Lipids
,
pubmed-meshheading:9776187-Male
,
pubmed-meshheading:9776187-Middle Aged
,
pubmed-meshheading:9776187-Patient Selection
,
pubmed-meshheading:9776187-Plasmids
,
pubmed-meshheading:9776187-Prospective Studies
pubmed:year
1998
pubmed:articleTitle
Alloantigen gene therapy for squamous cell carcinoma of the head and neck: results of a phase-1 trial.
pubmed:affiliation
Department of Otolaryngology, University of Cincinnati Medical Center, Ohio 45267-0528, USA. lyon.gleich@uc.edu
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase I